Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Arch Therapeutics, Inc. | PRESIDENT AND CHIEF EXECUTIVE, Director | Warrants (right to buy) | 13.7K | Aug 31, 2023 | Direct | ||
Arch Therapeutics, Inc. | PRESIDENT AND CHIEF EXECUTIVE, Director | Common Stock | 6.86K | Aug 31, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ARTH | Arch Therapeutics, Inc. | Aug 31, 2023 | 2 | $1.89K | 4 | Sep 8, 2023 | PRESIDENT AND CHIEF EXECUTIVE, Director |
ARTH | Arch Therapeutics, Inc. | Nov 10, 2022 | 1 | $0 | 4 | Nov 10, 2022 | PRESIDENT AND CHIEF EXECUTIVE |
ARTH | Arch Therapeutics, Inc. | Jul 6, 2022 | 3 | $24K | 4 | Jul 8, 2022 | PRESIDENT AND CHIEF EXECUTIVE |
ARTH | Arch Therapeutics, Inc. | Sep 27, 2021 | 2 | $0 | 4 | Oct 1, 2021 | President, CEO and Director, Director |